Cargando…
Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis
Pharmacological stabilization of hypoxia-inducible factor (HIF) through prolyl hydroxylase (PHD) inhibition limits mucosal damage associated with models of murine colitis. However, little is known about how PHD inhibitors (PHDi) influence systemic immune function during mucosal inflammation or the r...
Autores principales: | Keely, Simon, Campbell, Eric L., Baird, Alan W., Hansbro, Philip M., Shalwitz, Robert A., Kotsakis, Anna, McNamee, Eoin N., Eltzschig, Holger K., Kominsky, Douglas J., Colgan, Sean P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772994/ https://www.ncbi.nlm.nih.gov/pubmed/23695513 http://dx.doi.org/10.1038/mi.2013.29 |
Ejemplares similares
-
Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor
por: Wang, Ruth X., et al.
Publicado: (2021) -
Dynamics of Prolyl Hydroxylases Levels During Disease Progression in Experimental Colitis
por: Bakshi, Hamid A., et al.
Publicado: (2019) -
The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer
por: Kennel, Kilian B., et al.
Publicado: (2022) -
Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis
por: Masterson, Joanne C, et al.
Publicado: (2015) -
The role of HIF prolyl hydroxylases in tumour growth
por: Jokilehto, Terhi, et al.
Publicado: (2010)